| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
| Purification: |
Affinity purification |
| Concentration: |
Lot specific |
| Dilution Range: |
WB:1:1000-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MINPP1 |
| Gene ID: |
9562 |
| Uniprot ID: |
MINP1_HUMAN |
| Immunogen Region: |
298-487 |
| Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 298-487 of human MINPP1 (NP_004888.2). |
| Immunogen Sequence: |
KSPWCDVFDIDDAKVLEYLN DLKQYWKRGYGYTINSRSSC TLFQDIFQHLDKAVEQKQRS QPISSPVILQFGHAETLLPL LSLMGYFKDKEPLTAYNYKK QMHRKFRSGLIVPYASNLIF VLYHCENAKTPKEQFRVQML LNEKVLPLAYSQETVSFYED LKNHYKDILQSCQTSEECEL ARANSTSDEL |
| Tissue Specificity | Widely expressed with highest levels in kidney, liver, cerebellum and placenta. |
| Post Translational Modifications | N-glycosylated. |
| Function | Multiple inositol polyphosphate phosphatase that hydrolyzes 1D-myo-inositol 1,3,4,5,6-pentakisphosphate (InsP52OH) and 1D-myo-inositol hexakisphosphate (InsP6) to a range of less phosphorylated inositol phosphates. This regulates the availability of these various small molecule second messengers and metal chelators which control many aspects of cell physiology. Has a weak in vitro activity towards 1D-myo-inositol 1,4,5-trisphosphate which is unlikely to be physiologically relevant. By regulating intracellular inositol polyphosphates pools, which act as metal chelators, it may control the availability of intracellular calcium and iron, which are important for proper neuronal development and homeostasis. May have a dual substrate specificity, and function as a 2,3-bisphosphoglycerate 3-phosphatase hydrolyzing 2,3-bisphosphoglycerate to 2-phosphoglycerate. 2,3-bisphosphoglycerate (BPG) is formed as part of the Rapoport-Luebering glycolytic bypass and is a regulator of systemic oxygen homeostasis as the major allosteric effector of hemoglobin. |
| Protein Name | Multiple Inositol Polyphosphate Phosphatase 12 -3-Bisphosphoglycerate 3-Phosphatase2 -3-Bpg Phosphatase |
| Database Links | Reactome: R-HSA-1855231 |
| Cellular Localisation | Endoplasmic Reticulum LumenSecretedCell MembraneAlso Associated With The Plasma Membrane In Erythrocytes |
| Alternative Antibody Names | Anti-Multiple Inositol Polyphosphate Phosphatase 1 antibodyAnti-2 -3-Bisphosphoglycerate 3-Phosphatase antibodyAnti-2 -3-Bpg Phosphatase antibodyAnti-MINPP1 antibodyAnti-MIPP antibodyAnti-UNQ900 antibodyAnti-PRO1917 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
